Ben Davey is a Managing Director, Head of Equity Capital Markets at Wedbush Securities. He has previously served as the Head of Equity Syndicate/Equity Capital Markets at ThinkEquity Partners (ThinkPanmure), Vice President/ECM at JP Morgan Chase and VP/Deal Captain at Hambrecht & Quist. Ben joined Pacific Growth in October 2007 and has over 12 years in the industry while executing over 200 equity offerings.
Ben holds an MBA from Thunderbird and a BS in Business & a BA Economics from Saint Mary’s College.
Kelly Lisbakken is a Managing Director in the Healthcare Investment Banking Group at Wedbush PacGrow, focusing on Biotechnology and Specialty Pharmaceuticals. Ms. Lisbakken joined Pacific Growth Equities in 2004, and has completed over 160 transactions with the firm, raising over $15 billion. Prior to joining Wedbush, Kelly worked at ICOS (now part of Eli Lilly), on Cialis and the PDE4 program.
Kelly holds an AB in Molecular Biology from Princeton University, where she completed her thesis under the direction of Dr. Thomas Shenk, the Elkins Professor in the Life Sciences, and former board member of Merck & Co.
Dan Bowen is a Managing Director and Director of Private Placements in the Healthcare Investment Banking Group at Wedbush PacGrow. Based in Minneapolis, Dan joins Wedbush after spending 11 years at Piper Jaffray’s Equity Private Placements Group, where he was head of the firm’s healthcare private placements. In addition, Dan previously worked in the Investment Banking Group at UBS, and was a Foreign Service Officer in the U.S. Department of State for 11 years, where he held a variety of international and domestic positions. Over the past 15 years, Dan has completed 40 private equity transactions, representing over $1.5 billion in equity and debt placements.
Dan is a graduate of Amherst College, where he earned his Bachelor of Science in Russian Studies, and has an MBA from the Fuqua School of Business at Duke University.
Eric Tansky is a Managing Director in the Healthcare Investment Banking Group at Wedbush PacGrow, based in the firm’s New York office and focusing on the Medical Technology sector. Focusing on medical devices investment banking for over ten years, Eric has extensive experience in medical device M&A and financing transactions. Eric joins Wedbush after spending a majority of his investment banking career at Jefferies Healthcare Investment Banking, Credit Suisse, and Merrill Lynch. Over the past 10 years, Eric has completed 45 transactions, representing over $62 billion in transaction value.
Eric is a graduate of the United States Naval Academy, has an MBA from Columbia University, and spent several years as an OR-focused Orthopedic Consultant.
The background of this firm and investment professionals may be found on FINRA's BrokerCheck.